4.4 Article

The role of gut microbiota in intestinal and liver diseases

期刊

LABORATORY ANIMALS
卷 53, 期 3, 页码 271-280

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/0023677218818605

关键词

inflammatory bowel disease; cancer; coeliac disease; dysbiosis; non-alcoholic fatty liver disease

资金

  1. Czech Science Foundation [15-09518S, 15-07268S, 16-06326S, 17-07332S, 17-09869S]
  2. Czech Health Research Council [15-28064A, 15-30782A, 17-31248A]
  3. Charles University in Prague, Faculty of Medicine in Hradec Kralove ['PRVOUK' P37/10]
  4. [RVO: 61388971]

向作者/读者索取更多资源

The world-wide incidence of many immune-mediated and metabolic diseases, including those of the intestines and liver, is steadily increasing. Gut microbiota plays a central role in the pathogenesis of these diseases as it mediates environmental changes to the intestinal immune system. Various environmental factors including diet, food additives and medication also trigger the compositional and functional alterations of microbiota, that is, dysbiosis, and this dysbiosis is closely associated with many chronic inflammatory diseases. However, the causal relationship remains unclear for the majority of these diseases. In this review, we discuss essential epidemiological data, known pathogenetic factors including those of genetic and environmental nature, while mainly focusing on the role of gut microbiota in the development of selected intestinal and liver diseases. Using specific examples, we also briefly describe some of the most widely-used animal models including gnotobiotic models and their contribution to the research of pathogenetic mechanisms of the host-microbiota relationship.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据